|
Volumn 178, Issue 5, 2003, Pages 197-198
|
Injecting drug use in Australia: Needle/syringe programs prove their worth, but hepatitis C still on the increase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
VIRUS ANTIBODY;
AUSTRALIA;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG OVERDOSE;
EDITORIAL;
GOVERNMENT;
HEALTH CARE COST;
HEALTH PROGRAM;
HEPATITIS C;
HEPATITIS C VIRUS;
HEROIN DEPENDENCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
INFECTION RATE;
INJECTION;
INTRAVENOUS DRUG ABUSE;
LIVER CIRRHOSIS;
MORTALITY;
NEEDLE;
NONHUMAN;
OUTCOMES RESEARCH;
POPULATION RESEARCH;
POPULATION RISK;
VIRUS TRANSMISSION;
|
EID: 0037416408
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2003.tb05159.x Document Type: Editorial |
Times cited : (7)
|
References (11)
|